艾索基因 AXGN
$50.02 +$1.27 (+2.61%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $50.00 -0.04%
开盘$48.55
昨收$48.75
当日区间$48.14 – $50.29
成交量1.67M
市值$2.99B
市盈率（TTM）–
股息率–
AXGN 相关新闻
匹配 AxoGen 或代码 AXGN 的头条新闻，按最新排序。
- Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
- Truist Financial Maintains AxoGen(AXGN.US) With Buy Rating
- Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
- Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $53 正面
- Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60
- Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50 正面
- A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55
- CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
- A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $48 to $55
- A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $50 to $50
- Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
- CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $45 正面
- Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50 正面
- CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40
- Mizuho Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40
暂无评论——快来第一个聊聊 AXGN。
登录后参与讨论。